查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1929557

醫藥物流低溫運輸倉儲市場：按服務類型、溫度範圍、倉庫所有權、儲存期限和最終用戶分類的全球預測（2026-2032年）

Cold Chain Warehousing in Pharmaceutical Logistics Market by Service Type, Temperature Range, Warehouse Ownership, Storage Duration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年醫藥物流低溫運輸倉儲市場規模為 12 億美元，預計 2026 年將成長至 12.9 億美元，預計到 2032 年將達到 19.5 億美元，年複合成長率為 7.14%。

關鍵市場統計數據
基準年 2025 12億美元
預計年份：2026年 12.9億美元
預測年份 2032 19.5億美元
複合年成長率 (%) 7.14%

清晰的策略視角，洞察藥品低溫運輸倉儲日益嚴峻的挑戰，以及為何整合技術、合規性和基礎設施至關重要。

藥品低溫運輸是現代醫療保健服務體系的關鍵基石，它確保了對溫度敏感的治療藥物從生產到最終送達患者手中的安全運輸和儲存。生物製藥、細胞和基因療法以及mRNA疫苗的最新進展進一步提升了對精準溫度控制、可追溯性和快速反應的需求。因此，倉儲營運正從簡單的儲存設施發展成為技術複雜的樞紐，整合了環境控制系統、檢驗的包裝流程和即時監控，以維持產品療效並符合日益嚴格的法規結構。

快速的技術應用、日益嚴格的監管要求以及不斷變化的治療策略正在如何重塑低溫運輸倉儲營運和投資重點？

由於技術創新、監管日益嚴格以及產品特性不斷變化，醫藥低溫運輸倉儲營運正經歷變革。感測器技術和物聯網 (IoT) 連接的進步提高了端到端的可視性，實現了基於狀態的警報和自動糾正措施，從而減少了產品損失並有助於做好審核準備。同時，從機器人輔助托盤搬運到自動化貨架和檢索系統，倉庫自動化正在提高吞吐量，減少人為錯誤，並更有效地遵守受控環境規範。

評估近期美國關稅調整對醫藥物流採購、供應商策略和低溫運輸資本配置的多層次營運影響

近期貿易政策的調整，包括主要市場的關稅調整和進口法規更新，為管理國際低溫運輸的企業帶來了新的營運和成本的考量。關稅制度的變化會影響進口設備、檢驗包裝材料和模組化冷庫的到岸成本，進而影響採購週期以及本地供應商與全球供應商的選擇。除了設備之外，輔助商品和生產投入品的關稅也可能形成獎勵機制，鼓勵企業將部分倉儲資產遷回國內，並實現配送中心的區域化，從而降低跨境關稅和邊境延誤的風險。

細分、細緻的洞察，解釋了溫度控制要求、服務類型、最終用戶、所有權模式和儲存時間如何決定低溫運輸營運設計。

細分市場分析揭示了溫度控制水準、服務類型、終端使用者特徵、倉庫所有權模式和儲存時間要求等方面不同的營運和策略需求。常溫產品儲存設施強調穩定的氣候性能和持續監控，而冷凍和超低溫儲存則需要專門的冷凍系統、備用電源和檢驗的操作規程，以防止產品不可逆的劣化。冷藏配送運作和運輸的整合需要協調的交接和檢驗的包裝解決方案，以確保從倉庫到最終用戶處的溫度連續性。

區域趨勢和基礎設施的考量正在推動美洲、歐洲、中東和非洲以及亞太市場採取差異化的低溫運輸倉儲策略。

區域特徵正在塑造美洲、歐洲、中東和非洲以及亞太地區各具特色的低溫運輸策略，每個地區都擁有其獨特的監管、基礎設施和需求面特徵。在美洲，先進的物流網路和集中的製造群支撐著密集的冷藏生態系統，而跨境物流和清關則需要協調的文件和檢驗的運輸解決方案來確保合規性。歐洲、中東和非洲的特點是管理體制和基礎設施成熟度各不相同，因此需要採取本地化最佳化的策略，將集中式卓越中心與本地化的分銷樞紐相結合，才能有效地服務於其分散的醫療保健市場。

一家領先的低溫運輸倉儲供應商如何結合檢驗的基礎設施、數位化監管和服務創新，以滿足製藥業日益成長的需求

低溫運輸倉儲產業的主要企業將深厚的監管倉儲專業知識與對數位化監控和高可靠性基礎設施的投資相結合。一流的營運商實施檢驗的環境控制措施，維護嚴格的合格文件，並將遙測技術整合到中央控制中心，從而能夠對偏差做出預先回應。物流供應商和製藥企業之間的夥伴關係越來越注重以結果為導向的服務等級協議，這些協議與產品完整性指標掛鉤，而不僅僅是吞吐量或運轉率。

給經營團隊的可操作建議：整合基礎設施投資、數位化能力建設、勞動力發展和監管合規，以加強低溫運輸韌性

為了在保障產品完整性的同時有效管理營運風險，產業領導者應制定一項整合資本投資、數位轉型、人才培育和合規監管的策略。資本規劃應優先考慮冗餘電源系統、模組化超低溫區域以及經過驗證的監控檢驗，以便在發生安全漏洞後能夠進行持續的環境監測和快速的取證分析。同時，有針對性的數位化投資，例如物聯網遙測、雲端分析和安全可追溯性，可以透過減少損失和簡化合規報告流程來幫助降低長期營運風險。

採用嚴謹的混合方法研究途徑（相關人員訪談、營運案例分析和監管整合）得出切實可行的低溫運輸倉庫管理指導。

本研究採用多種方法，全面了解低溫運輸倉庫的動態。研究結合了對關鍵相關人員的訪談、營運案例分析以及監管指南的綜合解釋。主要研究內容包括對供應鏈經理、品質保證專業人員和物流營運人員的結構化訪談，以了解實際挑戰和行之有效的應對措施。營運案例分析則檢視了代表性設施的檢驗通訊協定、合格文件和業務連續性計劃，以識別準備工作和工程最佳實踐方面反覆出現的差距。

最後，我們提出了研究結果，這些結果表明，基礎設施、數位化和營運紀律是建立具有韌性的藥品低溫運輸倉庫的基礎。

總之，醫藥低溫運輸倉庫正處於一個轉折點，技術能力、監管審查和治療方法複雜性相互交織，迫使設施設計和營運規範必須達到更高標準。積極整合檢驗的基礎設施、持續監控和靈活服務模式的機構，將在維護產品完整性、快速送達患者以及應對供應鏈中斷方面佔據優勢。同樣，未能投資於冗餘、數位化可追溯性和員工能力的機構，則面臨產品損失增加、合規風險上升和聲譽受損的風險。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依服務類型分類的醫藥物流低溫運輸倉儲市場

  • 冷藏保管
  • 監控服務
  • 冷藏運輸
  • 附加價值服務

9. 依溫度範圍分類的醫藥物流低溫運輸倉庫市場

  • 管制室溫
  • 冷凍
  • 冷藏
  • 超低溫

第10章：以倉庫所有權類型分類的醫藥物流低溫運輸倉庫市場

  • 私人倉庫
  • 公共倉庫

第11章：醫藥物流低溫運輸倉儲市場（依儲存期分類）

  • 長期
  • 短期

第12章：以終端使用者分類的醫藥物流低溫運輸倉儲市場

  • 生技公司
  • 臨床研究所
  • 醫院和診所
  • 製藥公司

第13章：依地區分類的醫藥物流低溫運輸倉儲市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：按地區分類的醫藥物流低溫運輸倉儲市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：各國醫藥物流低溫運輸倉儲市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫藥物流低溫運輸倉儲市場

第17章：中國醫藥流低溫運輸倉儲市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agility Public Warehousing Company KSCP
  • AGT Food and Ingredients Inc.
  • Americold Logistics, LLC
  • Amerijet International, Inc.
  • AP Moller-Maersk A/S
  • Bollore SE
  • Ceva Logistics LLC
  • CLNG Cold Logistics Network AG
  • DB Schenker Logistics（Deutschland）GmbH
  • DHL Supply Chain Limited
  • DSV Panalpina A/S
  • Dussmann Service Deutschland GmbH
  • Envirotainer AB
  • FedEx Healthcare
  • Kuehne+Nagel International AG
  • Lineage Logistics Holdings, LLC
  • Nippon Express Co., Ltd.
  • Panasonic Corporation
  • Sinotrans Limited
  • United States Cold Storage, Inc.
  • UPS Supply Chain Solutions
  • Yusen Logistics Co., Ltd.
Product Code: MRR-0A3806951818

The Cold Chain Warehousing in Pharmaceutical Logistics Market was valued at USD 1.20 billion in 2025 and is projected to grow to USD 1.29 billion in 2026, with a CAGR of 7.14%, reaching USD 1.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.20 billion
Estimated Year [2026] USD 1.29 billion
Forecast Year [2032] USD 1.95 billion
CAGR (%) 7.14%

A clear strategic introduction to the evolving rigor of pharmaceutical cold chain warehousing and why integrating technology, compliance, and infrastructure matters now

The pharmaceutical cold chain is a critical backbone of contemporary healthcare delivery, enabling the safe movement and storage of temperature-sensitive therapies from production to patients. Recent advances in biologics, cell and gene therapies, and mRNA-based vaccines have intensified requirements for precise temperature control, traceability, and rapid response capabilities. Consequently, warehousing operations have evolved from simple storage facilities into technically complex nodes that integrate environmental control systems, validated packaging processes, and real-time monitoring to preserve product potency and comply with increasingly stringent regulatory frameworks.

As the industry adapts, stakeholders must harmonize operational procedures with digital oversight while maintaining uninterrupted cold environments across multimodal transport corridors. This introduction frames a strategic view of the cold chain warehousing ecosystem, emphasizing the interplay between infrastructure resilience, compliance rigor, and the rising expectations of speed and traceability. The subsequent sections examine how structural shifts, policy dynamics, segmentation characteristics, and regional variations are shaping decisions for pharmaceutical manufacturers, logistics providers, and health systems.

How rapid technological adoption, tighter regulatory expectations, and evolving therapeutic profiles are reshaping cold chain warehousing operations and investment priorities

The landscape of pharmaceutical cold chain warehousing is undergoing transformative shifts driven by technological innovation, regulatory tightening, and changing product profiles. Advances in sensor technologies and Internet of Things (IoT) connectivity have enhanced end-to-end visibility, enabling condition-based alerts and automated corrective actions that reduce product loss and support audit readiness. Simultaneously, warehouse automation-ranging from robotics-assisted pallet handling to automated racking and retrieval systems-has improved throughput, reduced human error, and enabled more consistent adherence to controlled environment specifications.

Regulatory expectations are also evolving; authorities increasingly require documented temperature control plans, validated cold storage systems, and demonstrable chain-of-custody records for high-risk biologics. In response, operators are investing in calibrated HVAC systems, redundant power solutions, and qualified monitoring platforms. Moreover, the diversification of therapeutic modalities toward sensitive biologics and ultra-low-temperature products is prompting a reconfiguration of facilities to include dedicated zones for Controlled Room Temperature, Frozen, Refrigerated, and Ultra Low Temperature storage, all with discrete monitoring and validation regimes. These combined shifts are pushing the sector toward integrated solutions that blend resilient infrastructure with digitalized oversight, enabling faster response to supply disruptions and higher assurance of product integrity.

Assessing the layered operational consequences of recent United States tariff changes on procurement, supplier strategy, and cold chain capital allocation in pharmaceutical logistics

Recent trade policy actions, including tariff adjustments and updated import controls in key markets, have introduced new operational and cost considerations for companies managing international cold chain flows. Changes in tariff regimes affect the landed cost of imported equipment, validated packaging materials, and modular cold rooms, which in turn influence procurement timelines and the selection of local versus global suppliers. Beyond equipment, tariffs on ancillary goods and manufacturing inputs can create incentive structures that encourage onshoring of certain storage assets or regionalization of distribution hubs to reduce exposure to cross-border duties and border delays.

In practice, supply chain planners are recalibrating sourcing strategies to prioritize supplier diversification and strategic inventory placement in markets less exposed to tariff volatility. Logistics partners are reevaluating routing and consolidation practices to minimize customs friction while retaining cold integrity across transit. Importantly, these tariff-induced shifts must be balanced against regulatory and quality requirements that may necessitate specialized cold storage investments regardless of cost pressures. As a result, many organizations are opting for hybrid approaches that combine localized critical storage capacity with centralized, compliance-focused warehouses to maintain both operational flexibility and regulatory confidence.

Nuanced segmentation-driven insights explaining how temperature regimes, service types, end-users, ownership models, and storage durations dictate cold chain operational design

Segmentation analysis reveals distinct operational and strategic requirements across temperature regimes, service modalities, end-user profiles, warehouse ownership models, and storage duration demands. Facilities supporting Controlled Room Temperature products emphasize stable HVAC performance and continuous monitoring, whereas Frozen and Ultra Low Temperature storage require specialized refrigeration systems, backup power, and validated handling protocols to avoid irreversible product degradation. Refrigerated distribution operations and refrigerated transportation interfaces demand coordinated handoffs and validated packaging solutions to maintain thermal continuity from warehouse to point of care.

Service differentiation also influences technology investment: providers focused on monitoring services invest heavily in telemetry and cloud-based analytics, while operators offering value-added services prioritize scalable cleanroom spaces, kitting, and lot-level traceability. End users shape demand patterns and compliance posture; biotechnology companies and clinical research organizations require flexible short-term storage with frequent access for trials, while pharmaceutical manufacturers and hospitals may prioritize long-term, high-integrity storage with stringent documentation. Ownership dynamics-private warehouse versus public warehousing-drive how capital investments and service level agreements are structured, and storage duration considerations differentiate operational flows between long term archival storage and short term surge capacity for seasonal vaccination campaigns or clinical trial launches. Collectively, these segmentation dimensions inform facility design, staffing competencies, validation schedules, and partner selection criteria.

Regional dynamics and infrastructure considerations driving differentiated cold chain warehousing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics are shaping cold chain strategies in diverse ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each region presenting unique regulatory, infrastructure, and demand-side characteristics. In the Americas, advanced logistics networks and concentrated biomanufacturing clusters support high-density cold storage ecosystems, yet cross-border flows and customs processes require coordinated documentation and validated transport solutions to maintain compliance. Europe, the Middle East & Africa are characterized by a mosaic of regulatory regimes and infrastructure maturity levels, which drives the need for regionally tailored strategies that combine centralized centers of excellence with localized distribution nodes to reach disparate healthcare markets effectively.

In the Asia-Pacific region, accelerating clinical development activity and expanding pharmaceutical manufacturing have increased demand for both urban refrigerated capacity and remote ultra-low-temperature capabilities. Regional power reliability, customs processing times, and the availability of trained cold chain personnel influence how companies prioritize investments in redundant systems and training programs. Across all regions, convergence toward harmonized temperature monitoring standards and digital traceability protocols is reducing variability in compliance expectations, while regional trade agreements and logistical corridors continue to influence the placement of strategic warehouses and cross-dock facilities.

How top cold chain warehousing providers are combining validated infrastructure, digital monitoring, and service innovation to meet heightened pharmaceutical expectations

Leading companies in cold chain warehousing combine deep domain expertise in regulated storage with investments in digital monitoring and resilient infrastructure. Best-in-class operators deploy validated environmental controls, maintain rigorous qualification documentation, and integrate telemetry into centralized control centers that enable proactive response to excursions. Partnerships between logistics providers and pharmaceutical manufacturers increasingly emphasize outcome-based service level agreements that link performance to product integrity metrics rather than solely to throughput or occupancy rates.

Innovation among key firms is concentrated in modular facility design, enabling rapid scaling of controlled temperature zones and seamless integration with last-mile refrigerated transport providers. Strategic collaborations with technology vendors have accelerated the adoption of continuous monitoring platforms, blockchain-enabled traceability pilots, and remote auditing capabilities. Additionally, companies are broadening service portfolios to include regulatory advisory services, on-site kitting and labeling, and clinical trial logistics to capture upstream value and to reduce handling complexity for temperature-sensitive therapies. These integrated approaches position leading providers to meet the heightened quality and speed expectations of contemporary pharmaceutical supply chains.

Actionable recommendations for executives to align infrastructure investments, digital capability building, workforce development, and regulatory engagement to strengthen cold chain resilience

Industry leaders should pursue a coordinated strategy that aligns facility investment, digital transformation, workforce development, and regulatory engagement to preserve product integrity while controlling operational risk. Capital planning must prioritize redundant power systems, modular ultra-low-temperature zones, and validated monitoring platforms that support continuous environmental oversight and enable rapid forensic analysis after any excursions. Concurrently, targeted digital investments-specifically in IoT telemetry, cloud analytics, and secure traceability-can reduce shrinkage and streamline compliance reporting, thereby lowering long-term operational risk.

Training and competency development are equally important; cross-functional teams that include quality assurance, engineering, and logistics should participate in scenario-based drills and validation exercises to ensure coordinated responses to temperature excursions and power disruptions. Strategic partnerships with regional providers can complement centralized capabilities to reduce tariff exposure and shorten lead times. Leaders should also reexamine contractual terms to align incentives around product integrity outcomes, and proactively engage with regulators to adopt emerging guidance for digital records and remote monitoring. Taken together, these actions will strengthen resilience and create a flexible platform for scaling new therapeutic requirements.

A rigorous mixed-method research approach blending stakeholder interviews, operational case review, and regulatory synthesis to derive pragmatic cold chain warehousing guidance

This research relied on a multi-method approach to develop a holistic understanding of cold chain warehousing dynamics, combining primary stakeholder interviews, operational case reviews, and synthesis of regulatory guidance. Primary inputs included structured interviews with supply chain leaders, quality assurance professionals, and logistics operators to capture real-world challenges and proven mitigation practices. Operational case reviews examined validated protocols, qualification documents, and continuity plans from representative facilities to identify recurring readiness gaps and engineering best practices.

Secondary analysis incorporated publicly available regulatory standards, industry guidance, and technology capability descriptions to contextualize operational findings and to assess conformity with current compliance expectations. Triangulation across these inputs enabled the identification of common themes related to monitoring, redundancy, and segmentation-driven requirements. The methodology emphasized qualitative rigor, traceability of assertions to source inputs, and the development of pragmatic recommendations intended to be directly applicable to decision-makers responsible for cold chain continuity and product integrity.

Concluding insights that synthesize infrastructure, digitalization, and operational discipline as the pillars for resilient pharmaceutical cold chain warehousing

In conclusion, cold chain warehousing for pharmaceutical logistics is at an inflection point where technological capability, regulatory scrutiny, and therapeutic complexity intersect to raise the bar for facility design and operational discipline. Organizations that proactively integrate validated infrastructure, continuous monitoring, and flexible service models will be better positioned to preserve product integrity, accelerate time to patient, and respond to supply chain disruptions. Equally, those that neglect investments in redundancy, digital traceability, and workforce competence risk elevated product loss, compliance exposure, and reputational harm.

Looking forward, the sector will continue to evolve toward greater digital integration, regional optimization of warehousing footprints, and service models that emphasize outcome-based accountability. Firms that combine strategic capital allocation with disciplined operational practices and collaborative vendor relationships can transform cold chain warehousing from a cost center into a competitive enabler of next-generation therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Service Type

  • 8.1. Cold Storage
  • 8.2. Monitoring Services
  • 8.3. Refrigerated Transportation
  • 8.4. Value Added Services

9. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Temperature Range

  • 9.1. Controlled Room Temperature
  • 9.2. Frozen
  • 9.3. Refrigerated
  • 9.4. Ultra Low Temperature

10. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Warehouse Ownership

  • 10.1. Private Warehouse
  • 10.2. Public Warehouse

11. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Storage Duration

  • 11.1. Long Term
  • 11.2. Short Term

12. Cold Chain Warehousing in Pharmaceutical Logistics Market, by End User

  • 12.1. Biotechnology Companies
  • 12.2. Clinical Research Organizations
  • 12.3. Hospitals And Clinics
  • 12.4. Pharmaceutical Manufacturers

13. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cold Chain Warehousing in Pharmaceutical Logistics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cold Chain Warehousing in Pharmaceutical Logistics Market

17. China Cold Chain Warehousing in Pharmaceutical Logistics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agility Public Warehousing Company K.S.C.P.
  • 18.6. AGT Food and Ingredients Inc.
  • 18.7. Americold Logistics, LLC
  • 18.8. Amerijet International, Inc.
  • 18.9. AP Moller - Maersk A/S
  • 18.10. Bollore SE
  • 18.11. Ceva Logistics LLC
  • 18.12. CLNG Cold Logistics Network AG
  • 18.13. DB Schenker Logistics (Deutschland) GmbH
  • 18.14. DHL Supply Chain Limited
  • 18.15. DSV Panalpina A/S
  • 18.16. Dussmann Service Deutschland GmbH
  • 18.17. Envirotainer AB
  • 18.18. FedEx Healthcare
  • 18.19. Kuehne + Nagel International AG
  • 18.20. Lineage Logistics Holdings, LLC
  • 18.21. Nippon Express Co., Ltd.
  • 18.22. Panasonic Corporation
  • 18.23. Sinotrans Limited
  • 18.24. United States Cold Storage, Inc.
  • 18.25. UPS Supply Chain Solutions
  • 18.26. Yusen Logistics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ULTRA LOW TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ULTRA LOW TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ULTRA LOW TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRIVATE WAREHOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRIVATE WAREHOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRIVATE WAREHOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 115. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 133. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 138. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 139. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY WAREHOUSE OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA COLD CHAIN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)